Antigen-specific T Cell Therapy for Patients With Relapsed Refractory Multiple Myeloma
Clinical trial NCT04505813 · SUSPENDED
Trial details
- NCT number
- NCT04505813
- Sponsor
- NexImmune Inc.
- Status
- SUSPENDED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-17
- Primary completion
- 2024-11-30
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.